TrialCancer medicine2015

Phase I/II trial of capecitabine, oxaliplatin, and irinotecan in combination with bevacizumab in first line treatment of metastatic colorectal cancer.

Shouki Bazarbashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.